Ascenion is offering another workshop in its Life Science Digital Hub, funded by GO-Bio initial:  ...

Ascenion's portfolio company Allogenetics has closed a significant pre-Series A financing round. The ...

The US Food and Drug Administration (FDA) has granted orphan drug designation to HepaRegeniX’s ...

The former x-cardiac GmbH has broadened its business focus and is now operating as Ascléa GmbH. At ...

Ascenion’s portfolio company sThesis GmbH is selected as one of eight international teams to receive ...